Vascular Disease Clinical Trials
The vascular disease clinical trials team is interested in seeing how exciting new vascular disease devices and drugs can help to improve the outcomes and quality of life for those living with vascular diseases.
Feel free to call or e-mail the Knight Cardiovascular Institute research team at 503-418-1964 or by emailing heartresearch@ohsu.edu. You will then be forwarded to the appropriate research team member who will be able to see if you qualify for any of the clinical trials being offered at OHSU.
You can also find all the of heart failure clinical trials, that are currently enrolling patients, below.
Fibrillin Surveillance
Use of Plasma-detected Fibrillin Peptide Fragments for pre- and Post-operative Aortic Aneurysm and Dissection Surveillance
Primary investigator:
Cherrie Abraham, M.D., F.R.C.S.C.
Protocol number:
IRB00016252
Study purpose:
This study aims to determine the sensitivity of circulating fibrillin fragment levels to detect and surveillance changes in aortic pathology pre- and post-operatively.
Contact:
Derek Darby (Study Coordinator)
503-418-1964
heartresearch@ohsu.edu
GORE TBE
Evaluation of the GORE® TAG® Thoracic Branch Endoprosthesis (TBE Device) in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta
Primary investigator:
Cherrie Abraham, MD., F.R.C.S.C.
Protocol number:
IRB00016197
Study purpose:
This is a study device trial that aims to evaluate the safety and effectiveness of the thoracic branch endoprosthesis (TBE) in subjects with aortic lesions.
Contact:
Derek Darby (Study Coordinator)
503-418-1964
heartresearch@ohsu.edu
Zenith p-Branch Study
Primary investigator:
Cherrie Abraham, M.D., F.R.C.S.C.
Protocol number:
IIRB00015370
Study purpose:
This clinical investigation is intended to evaluate the safety and effectiveness of the Zenith® p-Branch™ in combination with Atrium iCAST™ covered stents for the treatment of pararenal or juxtarenal aortic aneurysms.
Contact:
Derek Darby (Study Coordinator)
503-418-1964
heartresearch@ohsu.edu